To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

NCT06473948 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: JMKX001899
DRUG: JMKX001899
DRUG: JMKX001899
DRUG: Placebo

Sponsor

Jemincare